Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Translational Lung Cancer Research|May 19, 2025
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN studyMar Varela, Cristina Teixidó, Carlos Álvarez-Fernández, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2024
Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor RegistryEnric Carcereny, Delvys Rodriguez-Abreu, Rafael Lopez, et al.Journal of the American Heart Association|February 12, 2026
Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by KlothoSara Vázquez-Sánchez, Ana Blasco, Marina Polo-Salguero, et al.Cancer|June 14, 2017
Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology GroupMariano Provencio, Ana Royuela, María Torrente, et al.Cancers|September 23, 2022
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing MutationRoberto Serna-Blasco, Estela Sánchez-Herrero, Lucía Robado de Lope, et al.Frontiers in Oncology|August 12, 2021
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET StudyEloisa Jantus-Lewintre, Bartomeu Massutí Sureda, José Luis González Larriba, et al.Molecular Oncology|September 19, 2019
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisionsSergio Villatoro, Clara Mayo-de-Las-Casas, Núria Jordana-Ariza, et al.ESMO Open|November 20, 2020
Lung cancer symptoms at diagnosis: results of a nationwide registry studyAlberto Ruano-Raviña, Mariano Provencio, Virginia Calvo de Juan, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?Mariano Provencio, Pilar Sabín, José Gómez Codina, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE studyAlberto Carmona-Bayonas, Paula Jiménez-Fonseca, Juan Virizuela Echaburu, et al.Pageof 10